此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Study to Observe the Capability to Absorb Calcium as an Measure of Adequate Levels of Vitamin D

2014年12月30日 更新者:John F. Aloia, MD、Winthrop University Hospital

Calcium Absorption Efficiency As An Indicator For Vitamin D Sufficiency

The purpose of this study is to determine the capability to absorb calcium as a measure of the sufficient levels of Vitamin D. Calcium absorption will be measured at baseline and after vitamin D3, by dual calcium isotope technique using stable isotopes in post menopausal women between the ages 50 and 70yrs. Subjects will have a screening visit, first and final visits. Subjects will be randomly assigned to a placebo or daily doses of vitamin D3. The specific aim of this study is to determine the level of vitamin D that will maximize the absorption of calcium and establish the relationship between the administered calcium dose and the actual absorbed calcium dose versus administered dose of Vitamin D and the serum levels of Vitamin D.

研究概览

详细说明

The specific aims of this project are:

  1. To determine the level of 25OHD that maximizes calcium absorption efficiency.
  2. To describe the dose response curve of calcium absorption to vitamin D intake and serum 25OHD.

This will be a randomized, double-blind, placebo-controlled trial of healthy postmenopausal females to determine the individual and combined effects of calcium and vitamin D supplementation.70 female participants, ages 50 to 70 years of age who are menopausal for over 1 year will be recruited into the study . The patients participation in this study will last about 10 weeks. Approximately 70 subjects from Winthrop University Hospital and the surrounding area will participate in this study. There is a total of 3 visits. Patients will be fasting for all visits. The first visit is a screening visit to determine if the patients qualify.

At visit 2, the patients will be given a light breakfast and asked to drink an 8 ounce glass of milk or calcium fortified orange juice containing a calcium isotope. After breakfast, the doctor or nurse will start an intravenous infusion and inject the patient with an IV solution containing a calcium isotope. This is a stable calcium isotope that is not radioactive and has no known toxicity. The patients will also be asked to collect a 24 hour urine and return it to us the next day.

The volunteers will be divided into four groups:

The first group will take 800 iu daily of vitamin D supplementation. The second group will take 2000 iu daily of vitamin D.The third group will take 4000 iu vitamin D and the fourth group will only take placebos. Visit 3 is essentially the same as visit 2, with subjects returning unused study medication and given new tablets

Food frequency questionnaires will be filled out at the initial visit and final visit. Diet will be assessed using 3-day diet history form and NutritionPro analysis software. Patients will be asked to refrain from taking other vitamin D supplements and to continue their usual calcium intake.

研究类型

介入性

注册 (实际的)

76

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • New York
      • Mineola、New York、美国、11501
        • Winthrop University Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

50年 至 70年 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

女性

描述

Inclusion Criteria:

Post menopausal women between the ages 50-70 yrs.

Exclusion Criteria:

  1. Any chronic medical illness including diabetes mellitus, history of myocardial infarction, or heart failure, malignancy, uncontrolled hypertension, history of anemia, leukemia, or other hematologic abnormalities, lupus, rheumatoid arthritis, or other rheumatologic disease, or kidney disease of any kind as determined by history and physical examination.
  2. Subjects with a BMI >35kg/m2
  3. Use of medication that influences vitamin D and bone metabolism (i.e. anticonvulsant medications, glucocorticoids, HAART [AIDS treatment], antirejection medications, high dose diuretics etc).
  4. Significant deviation from normal either in history, physical examination, or laboratory tests as evaluated by the primary investigator.
  5. Patients with a history of hypercalciuria ( Urine calcium:creatinine ratio > 0.37 , hypercalcemia ( serum calcium >10.21, nephrolithiasis, and active sarcoidosis will also be excluded.
  6. Unexplained weight loss >15% during the previous year or history of anorexia nervosa
  7. Participation in another investigational trial in the past 30 days prior to the screening evaluation.
  8. Patients reporting alcohol intake greater than 2 drinks daily.
  9. Subjects with baseline 25-OHD level greater than 70 nmol /L will be excluded.
  10. Smokers greater than one pack per day will be excluded
  11. Dietary calcium intake greater than 2000 mg will be excluded
  12. Participants who have history of allergy to milk, gluten or orange juice will be excluded
  13. Participants willing not to forego multivitamins and vitamin D supplements during the study -

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:诊断
  • 分配:随机化
  • 介入模型:单组作业
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
实验性的:Post Menopausal
post menopausal women between the ages 50-70 yrs.
Dual isotope technique using stable isotopes
其他名称:
  • Kinetic study
  • dual stable isotope

研究衡量的是什么?

主要结果指标

结果测量
大体时间
To determine the level of 25OHD that maximizes calcium absorption efficiency.
大体时间:3 months
3 months

次要结果测量

结果测量
大体时间
To describe the dose response curve of calcium absorption to vitamin D intake and serum 25OHD
大体时间:3 months
3 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:John F Aloia, MD、Winthrop University Hospital

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2010年12月1日

初级完成 (实际的)

2013年12月1日

研究完成 (实际的)

2013年12月1日

研究注册日期

首次提交

2010年5月5日

首先提交符合 QC 标准的

2010年5月5日

首次发布 (估计)

2010年5月7日

研究记录更新

最后更新发布 (估计)

2014年12月31日

上次提交的符合 QC 标准的更新

2014年12月30日

最后验证

2014年12月1日

更多信息

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

维生素 D 缺乏症的临床试验

Dual isotope technique的临床试验

3
订阅